Climate Change Data

iTeos Therapeutics

Climate Impact & Sustainability Data (2022, 2023)

Reporting Period: 2022

Environmental Metrics

Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed

ESG Focus Areas

  • Employee well-being
  • Diversity and Inclusion
  • Employee engagement and talent development
  • Environmental footprint reduction
  • Quality
  • Compliance
  • Information Security
  • Community Involvement

Environmental Achievements

  • Eco-Partnership with Graine de vie for tree planting to compensate ecological footprint
  • Approximately 20% of company cars in Belgium are electric or hybrid

Social Achievements

  • 95% employee engagement survey participation rate with strong results exceeding benchmarks
  • Various charitable initiatives (European Leukodystrophies Association, iTeos On the Move, iTeos Moves for Ukraine), totaling significant donations.
  • Women represent 58% of the global workforce and 43% of leadership positions at Director level or above.

Governance Achievements

  • 100% of employees certified to have read, understood, and will comply with the Code of Business Conduct and Ethics.
  • Anonymous and confidential whistleblower hotline managed by a third party.
  • Dedicated Information Security team and processes to protect sensitive data.

Climate Goals & Targets

Long-term Goals:
  • Not disclosed
Medium-term Goals:
  • Increase percentage of electric/hybrid company cars in Belgium
Short-term Goals:
  • Not disclosed

Environmental Challenges

  • Not disclosed
Mitigation Strategies
  • Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement
  • Thorough selection and qualification process for vendors, including RFP, quality questionnaires, certifications, audits

Climate-Related Risks & Opportunities

Physical Risks
  • Not disclosed
Transition Risks
  • Not disclosed
Opportunities
  • Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: ISO 9001

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

  • 3. Good health and well-being
  • 4. Quality education
  • 5. Gender equality
  • 8. Decent work and economic growth
  • 10. Reduced inequalities
  • 11. Sustainable cities and communities
  • 12. Responsible consumption and production
  • 13. Climate action
  • 16. Peace, justice and strong institutions

Not disclosed

Sustainable Products & Innovation

  • Not disclosed

Awards & Recognition

  • Not disclosed

Reporting Period: 2023

Environmental Metrics

ESG Focus Areas

  • Environmental
  • Social
  • Governance

Environmental Achievements

  • Partnered with Graine de vie to compensate ecological footprints through tree planting.
  • Partnered with Forest Connection Fund to reforest land around Brussels.
  • Approximately 20% of company cars in Belgium are electric or hybrid.

Social Achievements

  • Donated €10,000 to research on Leukodystrophies.
  • Donated €25,000 to Samu Social to support their work in Ukraine.
  • Raised €9,000 for Relay for Life, becoming the largest sponsor in Charleroi.

Governance Achievements

  • Adherence to international labor standards and relevant laws.
  • Strict enforcement of procedures following The Declaration of Helsinki and Good Clinical Practice (GCP).

Climate Goals & Targets

Supply Chain Management

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

  • Goal 3: Good Health and Well-being
  • Goal 4: Quality Education
  • Goal 5: Gender Equality
  • Goal 8: Decent Work and Economic Growth
  • Goal 10: Reduced Inequalities
  • Goal 11: Sustainable Cities and Communities
  • Goal 12: Responsible Consumption and Production
  • Goal 13: Climate Action
  • Goal 16: Peace, Justice and Strong Institutions

iTeos prioritizes these SDGs based on expertise, therapeutic areas, and business strategies.